NCT00098033View on ClinicalTrials.gov

Investigation of Clofarabine in Acute Leukemias

PHASE2CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

September 30, 2005

Conditions

Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia

Interventions

DRUG

clofarabine

All Listed Sponsors

lead

University of Texas

OTHER

NCT00098033 - Investigation of Clofarabine in Acute Leukemias | Biotech Hunter | Biotech Hunter